Mark Sculpher, PhD
Professor
University of York
Centre for Health Economics
Alcuin 'A' Block
Heslington
York
United Kingdom
YO105DD
Papers:
4K-6
WHEN AND WHERE IN THE TREATMENT PATHWAY IS IT APPROPRIATE TO USE NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C?